Giapal, Mardiza A.

HRN: 23-42-47  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2023
CEFUROXIME 750MG (VIAL)
08/02/2023
08/08/2023
IVTT
183 Mg Ivtt
Q8
Pcap-c
Waiting Final Action 
08/04/2023
CEFTRIAXONE 1G (VIAL)
08/04/2023
08/10/2023
IV
500mg
OD
Pcap C
Waiting Final Action 
08/04/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
08/04/2023
08/08/2023
OD
1.3ml
Od
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: